schizandrin has been researched along with Alzheimer Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, K; Cheng, X; Jia, Y; Jing, H; Qi, Y; Wu, B; Xiao, F; Yan, T | 1 |
| Bi, K; Cheng, X; Du, Y; Gong, G; Jia, Y; Qi, Y; Wu, B; Yan, T | 1 |
| Lu, Y; Piao, Z; Song, L; Yao, L; Zhang, L | 2 |
| Chen, ZX; Liu, MY; Wei, BB; Wei, MJ | 1 |
| Kong, L; Sun, H; Wang, XJ; Wang, XQ; Yu, JB; Zhang, AH; Zhang, QY | 1 |
| Cai, ZP; Huo, DS; Shao, G; Wang, H; Yang, ZJ; Zhang, M; Zhao, ZY | 1 |
7 other study(ies) available for schizandrin and Alzheimer Disease
| Article | Year |
|---|---|
Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
Topics: Alzheimer Disease; Animals; Cyclooctanes; Disease Models, Animal; Glutathione; Lignans; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Polycyclic Compounds; Polycyclic Sesquiterpenes; Superoxide Dismutase | 2019 |
Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway.
Topics: Alzheimer Disease; Animals; Apoptosis; Autophagy; Cyclooctanes; Disease Models, Animal; Drug Synergism; Inflammation; Lignans; Mice; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Polycyclic Sesquiterpenes; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; tau Proteins | 2020 |
Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer's disease rats.
Topics: Alzheimer Disease; Animals; Cognition; Cognitive Dysfunction; Cyclooctanes; Disease Models, Animal; Endoplasmic Reticulum Stress; Lignans; Male; Phytotherapy; Polycyclic Compounds; Rats, Wistar; Schisandra; Sirtuin 1; Streptozocin; Up-Regulation | 2020 |
Schisandrin Restores the Amyloid β-Induced Impairments on Mitochondrial Function, Energy Metabolism, Biogenesis, and Dynamics in Rat Primary Hippocampal Neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Cyclooctanes; Cytochromes c; Energy Metabolism; Hippocampus; Lignans; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Dynamics; Models, Biological; Neurons; Neuroprotective Agents; Organelle Biogenesis; Peptide Fragments; Polycyclic Compounds; Primary Cell Culture; Rats, Sprague-Dawley | 2021 |
Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex; Chromatography, Liquid; Cognitive Dysfunction; Cyclooctanes; Female; Hippocampus; Lignans; Male; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Neurotransmitter Agents; Nootropic Agents; Polycyclic Compounds; Presenilin-1; Tandem Mass Spectrometry | 2018 |
Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer's disease using chinmedomics approach.
Topics: Alzheimer Disease; Animals; Biomarkers, Pharmacological; Cyclooctanes; Dioxoles; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Lignans; Male; Medicine, Chinese Traditional; Metabolomics; Mice, Transgenic; Neuroprotective Agents; Polycyclic Compounds | 2018 |
The Effect of Schizandrol A-Induced DNA Methylation on SH-SY5YAB 1-40 Altered Neuronal Cell Line: A Potential Use in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cell Survival; Cyclooctanes; DNA Methylation; Gene Expression Regulation; Humans; Lignans; Neurons; Peptide Fragments; Polycyclic Compounds; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2015 |